Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 21 | 2021 | 206 | 5.540 |
Why?
|
| Drosophila Proteins | 26 | 2020 | 730 | 4.520 |
Why?
|
| Drosophila | 17 | 2023 | 792 | 3.580 |
Why?
|
| Glucosyltransferases | 14 | 2023 | 49 | 3.320 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 5 | 2022 | 10 | 2.340 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2022 | 44 | 2.150 |
Why?
|
| Alagille Syndrome | 3 | 2023 | 47 | 1.990 |
Why?
|
| Signal Transduction | 23 | 2021 | 4637 | 1.990 |
Why?
|
| Drosophila melanogaster | 14 | 2022 | 789 | 1.930 |
Why?
|
| Liver | 5 | 2023 | 1758 | 1.720 |
Why?
|
| Polysaccharides | 4 | 2021 | 141 | 1.560 |
Why?
|
| Glycosyltransferases | 5 | 2023 | 26 | 1.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2023 | 285 | 1.240 |
Why?
|
| Epidermal Growth Factor | 4 | 2018 | 122 | 1.240 |
Why?
|
| Glycosylation | 11 | 2021 | 125 | 1.050 |
Why?
|
| Serrate-Jagged Proteins | 5 | 2023 | 38 | 1.000 |
Why?
|
| Animals | 45 | 2023 | 34519 | 0.970 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2019 | 12 | 0.900 |
Why?
|
| Lipolysis | 1 | 2023 | 79 | 0.840 |
Why?
|
| Membrane Proteins | 8 | 2023 | 1551 | 0.840 |
Why?
|
| Wings, Animal | 3 | 2017 | 33 | 0.830 |
Why?
|
| Pentosyltransferases | 3 | 2018 | 20 | 0.810 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 80 | 0.800 |
Why?
|
| Bile Ducts | 2 | 2020 | 53 | 0.780 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2022 | 21 | 0.770 |
Why?
|
| Jagged-1 Protein | 6 | 2023 | 52 | 0.750 |
Why?
|
| Calcium-Binding Proteins | 4 | 2023 | 326 | 0.730 |
Why?
|
| Transcription Factors | 6 | 2017 | 2617 | 0.680 |
Why?
|
| Fucosyltransferases | 1 | 2019 | 29 | 0.650 |
Why?
|
| Protein Kinases | 2 | 2020 | 332 | 0.630 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 83 | 0.630 |
Why?
|
| Glycomics | 1 | 2018 | 15 | 0.620 |
Why?
|
| Genetic Background | 1 | 2018 | 7 | 0.610 |
Why?
|
| Liver Diseases | 2 | 2019 | 375 | 0.600 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 359 | 0.590 |
Why?
|
| Glycoproteins | 1 | 2020 | 362 | 0.580 |
Why?
|
| Xylose | 2 | 2017 | 9 | 0.560 |
Why?
|
| Heterozygote | 2 | 2020 | 674 | 0.560 |
Why?
|
| Imaginal Discs | 1 | 2017 | 10 | 0.550 |
Why?
|
| Sense Organs | 4 | 2006 | 19 | 0.530 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 126 | 0.530 |
Why?
|
| Rare Diseases | 1 | 2018 | 193 | 0.520 |
Why?
|
| Transgenes | 4 | 2014 | 336 | 0.510 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 17 | 0.490 |
Why?
|
| Photoreceptor Cells | 1 | 2014 | 91 | 0.450 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 560 | 0.430 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 86 | 0.430 |
Why?
|
| Eye Proteins | 1 | 2014 | 222 | 0.420 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2019 | 19 | 0.390 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 1277 | 0.390 |
Why?
|
| Gene Deletion | 1 | 2015 | 796 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2008 | 399 | 0.380 |
Why?
|
| Mutation | 13 | 2020 | 5956 | 0.360 |
Why?
|
| Mice | 11 | 2023 | 17864 | 0.350 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 2549 | 0.340 |
Why?
|
| Phenotype | 5 | 2023 | 4321 | 0.330 |
Why?
|
| Embryonic Development | 1 | 2011 | 212 | 0.320 |
Why?
|
| Genetic Techniques | 1 | 2010 | 107 | 0.320 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2020 | 25 | 0.300 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2023 | 99 | 0.280 |
Why?
|
| Ligands | 3 | 2018 | 544 | 0.280 |
Why?
|
| Genes, Insect | 2 | 2008 | 123 | 0.260 |
Why?
|
| Endocytosis | 2 | 2005 | 126 | 0.250 |
Why?
|
| Humans | 21 | 2022 | 126285 | 0.250 |
Why?
|
| Gene Silencing | 2 | 2023 | 243 | 0.240 |
Why?
|
| Glucose | 4 | 2014 | 881 | 0.240 |
Why?
|
| Neurons | 5 | 2006 | 1948 | 0.230 |
Why?
|
| Cell Lineage | 2 | 2006 | 353 | 0.230 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 120 | 0.230 |
Why?
|
| Zinc Fingers | 1 | 2004 | 120 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 1014 | 0.220 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2004 | 92 | 0.220 |
Why?
|
| Oocytes | 1 | 2005 | 298 | 0.210 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 2071 | 0.210 |
Why?
|
| Enterocytes | 1 | 2023 | 74 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2020 | 888 | 0.200 |
Why?
|
| Juvenile Hormones | 1 | 2002 | 4 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4463 | 0.200 |
Why?
|
| Body Patterning | 1 | 2002 | 123 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2006 | 913 | 0.180 |
Why?
|
| Cell Line | 6 | 2017 | 2735 | 0.180 |
Why?
|
| Repressor Proteins | 5 | 2008 | 832 | 0.180 |
Why?
|
| Cell Differentiation | 3 | 2004 | 1926 | 0.180 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Cholestasis | 1 | 2023 | 155 | 0.180 |
Why?
|
| Stem Cells | 2 | 2004 | 715 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2426 | 0.180 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2020 | 33 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2023 | 470 | 0.170 |
Why?
|
| Dystroglycans | 1 | 2020 | 7 | 0.170 |
Why?
|
| Lipids | 1 | 2023 | 524 | 0.170 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 338 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 765 | 0.160 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 66 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4466 | 0.150 |
Why?
|
| Portal Vein | 1 | 2019 | 91 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2020 | 210 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 2018 | 24 | 0.150 |
Why?
|
| Protein Binding | 4 | 2017 | 1749 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2002 | 1029 | 0.140 |
Why?
|
| Nervous System | 3 | 2006 | 129 | 0.130 |
Why?
|
| Base Sequence | 3 | 2014 | 3118 | 0.130 |
Why?
|
| Peptide Mapping | 1 | 2016 | 42 | 0.130 |
Why?
|
| Protein Folding | 2 | 2015 | 216 | 0.130 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 53 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2018 | 881 | 0.130 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 321 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3040 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2020 | 771 | 0.120 |
Why?
|
| Growth and Development | 1 | 2015 | 22 | 0.120 |
Why?
|
| Hepatic Insufficiency | 1 | 2015 | 1 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 199 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 214 | 0.120 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2015 | 33 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 480 | 0.120 |
Why?
|
| Molecular Sequence Data | 6 | 2007 | 3901 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2015 | 48 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 2719 | 0.120 |
Why?
|
| Enzyme Assays | 2 | 2015 | 11 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1725 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 123 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 128 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2014 | 449 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 980 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 318 | 0.100 |
Why?
|
| Temperature | 2 | 2011 | 309 | 0.100 |
Why?
|
| Biomarkers | 1 | 2022 | 3153 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 820 | 0.100 |
Why?
|
| Models, Biological | 5 | 2014 | 1470 | 0.100 |
Why?
|
| Receptors, Serotonin | 2 | 2003 | 45 | 0.100 |
Why?
|
| Factor VII | 1 | 2011 | 16 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 143 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2933 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 53 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 99 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 387 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 716 | 0.080 |
Why?
|
| Seizures | 1 | 2015 | 872 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 512 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2011 | 447 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 1135 | 0.080 |
Why?
|
| Apoptosis | 2 | 2005 | 1835 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2005 | 2393 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 362 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 277 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 43 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2818 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 813 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 664 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1713 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 91 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2006 | 807 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 962 | 0.060 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 43 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 123 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 12667 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 2003 | 17 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 371 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 1716 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14208 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 820 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 130 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 280 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3775 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 621 | 0.050 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2002 | 2 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2593 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2003 | 183 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 1341 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 670 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 163 | 0.040 |
Why?
|
| Child | 1 | 2020 | 24740 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2005 | 1021 | 0.040 |
Why?
|
| Pregnancy | 1 | 2011 | 7257 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 1111 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 564 | 0.040 |
Why?
|
| Spain | 1 | 2016 | 60 | 0.030 |
Why?
|
| Fucose | 1 | 2016 | 21 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 788 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 295 | 0.030 |
Why?
|
| Male | 4 | 2020 | 62009 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 104 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 158 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 93 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 163 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 397 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 382 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1257 | 0.030 |
Why?
|
| Alleles | 2 | 2008 | 1624 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 807 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 2 | 2003 | 6 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 294 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1768 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1560 | 0.020 |
Why?
|
| Female | 2 | 2020 | 67310 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 900 | 0.020 |
Why?
|
| Spodoptera | 1 | 2008 | 44 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2008 | 55 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 141 | 0.020 |
Why?
|
| Chromosomes | 1 | 2008 | 162 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 176 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 258 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 163 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 229 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 218 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 203 | 0.020 |
Why?
|
| Cyclin E | 1 | 2005 | 31 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 549 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 874 | 0.020 |
Why?
|
| Ataxins | 1 | 2005 | 114 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 290 | 0.020 |
Why?
|
| Rats | 2 | 2003 | 3762 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1089 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2005 | 162 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 350 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 673 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 113 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 60 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2005 | 162 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 484 | 0.010 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 6 | 0.010 |
Why?
|
| Meiosis | 1 | 2003 | 108 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 611 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 691 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 252 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 281 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 899 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 443 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1305 | 0.010 |
Why?
|
| Septum of Brain | 1 | 2000 | 5 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 297 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 29791 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2000 | 456 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2687 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 692 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3034 | 0.010 |
Why?
|